Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study
A major impediment to tuberculosis control in Africa is the difficulty in diagnosing active tuberculosis (TB), particularly in the context of HIV infection. We hypothesized that a unique host blood RNA transcriptional signature would distinguish TB from other diseases (OD) in HIV-infected and -uninf...
Saved in:
Published in: | PLoS medicine Vol. 10; no. 10; p. e1001538 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Public Library of Science
01-10-2013
Public Library of Science (PLoS) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A major impediment to tuberculosis control in Africa is the difficulty in diagnosing active tuberculosis (TB), particularly in the context of HIV infection. We hypothesized that a unique host blood RNA transcriptional signature would distinguish TB from other diseases (OD) in HIV-infected and -uninfected patients, and that this could be the basis of a simple diagnostic test.
Adult case-control cohorts were established in South Africa and Malawi of HIV-infected or -uninfected individuals consisting of 584 patients with either TB (confirmed by culture of Mycobacterium tuberculosis [M.TB] from sputum or tissue sample in a patient under investigation for TB), OD (i.e., TB was considered in the differential diagnosis but then excluded), or healthy individuals with latent TB infection (LTBI). Individuals were randomized into training (80%) and test (20%) cohorts. Blood transcriptional profiles were assessed and minimal sets of significantly differentially expressed transcripts distinguishing TB from LTBI and OD were identified in the training cohort. A 27 transcript signature distinguished TB from LTBI and a 44 transcript signature distinguished TB from OD. To evaluate our signatures, we used a novel computational method to calculate a disease risk score (DRS) for each patient. The classification based on this score was first evaluated in the test cohort, and then validated in an independent publically available dataset (GSE19491). In our test cohort, the DRS classified TB from LTBI (sensitivity 95%, 95% CI [87-100]; specificity 90%, 95% CI [80-97]) and TB from OD (sensitivity 93%, 95% CI [83-100]; specificity 88%, 95% CI [74-97]). In the independent validation cohort, TB patients were distinguished both from LTBI individuals (sensitivity 95%, 95% CI [85-100]; specificity 94%, 95% CI [84-100]) and OD patients (sensitivity 100%, 95% CI [100-100]; specificity 96%, 95% CI [93-100]). Limitations of our study include the use of only culture confirmed TB patients, and the potential that TB may have been misdiagnosed in a small proportion of OD patients despite the extensive clinical investigation used to assign each patient to their diagnostic group.
In our study, blood transcriptional signatures distinguished TB from other conditions prevalent in HIV-infected and -uninfected African adults. Our DRS, based on these signatures, could be developed as a test for TB suitable for use in HIV endemic countries. Further evaluation of the performance of the signatures and DRS in prospective populations of patients with symptoms consistent with TB will be needed to define their clinical value under operational conditions. Please see later in the article for the Editors' Summary. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The authors have declared that patent applications have been filed for the Disease Risk score (GB1201766.1) and TB/LTBI and TB/OD signatures (GB1213636.2). Conceived and designed the experiments: MK VJW NF STA AJB HMD BE RSH MLH FK PRL MM RJW LJC ML. Performed the experiments: MK VJW TO NB CMB LL FZ. Analyzed the data: MK VJW TO NF ACC RJW LJC ML. Contributed reagents/materials/analysis tools: MLH THO. Wrote the first draft of the manuscript: MK VJW NF RJW LJC ML. Contributed to the writing of the manuscript: MK VJW TO NF ACC HMD RSH RJW LJC ML. ICMJE criteria for authorship read and met: MK VJW TO NF STA NB CMB AJB ACC HMD BE RSH MLH FK PRL LL MM THO FZ RJW LJC ML. Agree with manuscript results and conclusions: MK VJW TO NF STA NB CMB AJB ACC HMD BE RSH MLH FK PRL LL MM THO FZ RJW LJC ML. Enrolled patients: TO NF NB FZ RJW. Contributed equally to this work with: Robert J. Wilkinson, Lachlan J. Coin, Michael Levin |
ISSN: | 1549-1676 1549-1277 1549-1676 |
DOI: | 10.1371/journal.pmed.1001538 |